0
rejuvant life tabs
Home Tags Editor’s picks

Tag: Editor’s picks

Tasmanian devil - gut bacteria
Investment

Gut bacteria start-up exits stealth with unique data

Eleanor Garth - 0
Metformin mice
Biotech

Metformin: a longevity drug for men only?

Eleanor Garth - 1
João Pedro de Magalhães
Biotech

Longevity pharmacology “promises to revolutionize medicine”

Eleanor Garth - 1
NAD+
Supplements

Longevity innovator enters mainstream retail

Eleanor Garth - 0
Greg Bailey - Juvenescence
Investment

Juvenescence scoops-up new longevity IP

Eleanor Garth - 0
aging
Economy

The trillion dollar upside to longevity

Christos Evangelou - 1
AgelessRx
Biotech

NAD+ and metformin: AgelessRx’s anti-aging platform

Eleanor Garth - 0
Jim Mellon
Features

We are what we eat: Jim Mellon exclusive

Phil Newman - 0
Massachusetts-based biotech announces closing of $16m seed round for stem cell therapy led by The Engine and Khosla Ventures.
Investment

Cellino closes $16m seed financing

Eleanor Garth - 0
Spineless mouse
Biotech

New Buck Institute study is treasure trove for longevity research

Margaretta Colangelo - 0

LATEST ARTICLES

Michael Zemel
Biotech

Leucine, weight loss and NAD+ boosting

Danny Sullivan - 0
Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...
Thyroid

Organoid to the rescue of the thyroid

EU longevity

Changing demographics warrant solid longevity foundation

Juvicell

Longevity supplements report: JUVICELL profile

Editor's picks

Popular posts

© Copyright 2021 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY